Cubist Pharmaceuticals (CBST): Q2 EPS of -$0.34 vs. consensus of $0.43. Revenue of $168.5M (+5%...

|By:, SA News Editor
Cubist Pharmaceuticals (CBST): Q2 EPS of -$0.34 vs. consensus of $0.43. Revenue of $168.5M (+5% Y/Y). (PR)